As GPR15 mediates colitis in T cell-dependent mouse models (5) and is highly expressed on presumptive pathogenic Th2 cells in the lamina propria of patients with UC (5), our results suggest the GPR15L–GPR15 interaction may prove useful as a therapeutic target for inflammatory diseases of the large intestines. This evidence concerns the gene GPR15LG and colitis.